TC
GPCR icon

TwinBeech Capital’s Structure Therapeutics GPCR Stock Holding History

TwinBeech Capital’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,268
Closed -$767K – 806
2024
Q4 		$767K Buy
28,268
+7,220
+34% +$256K 0.01% 406
2024
Q3 		$924K Sell
21,048
-21,613
-51% -$836K 0.02% 515
2024
Q2 		$1.68M Buy
+42,661
New +$1.75M 0.03% 351
2024
Q1 		– Sell
-24,290
Closed -$990K – 685
2023
Q4 		$990K Buy
+24,290
New +$1.39M 0.02% 489

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TwinBeech Capital's GPCR Position: Q1 2025 in Review

TwinBeech Capital sold out of Structure Therapeutics (GPCR) in Q1 2025, closing a stake of 28,268 shares — an estimated $767K sold.

TwinBeech Capital first reported a position in GPCR in Q4 2023 and held it in 4 quarters. The position peaked at $1.68M in Q2 2024. 150 funds tracked by Wall St. Rank hold GPCR as of Q1 2025.

  • TwinBeech Capital reported no remaining Structure Therapeutics position as of Q1 2025 after selling out during the quarter.
  • TwinBeech Capital sold 28,268 Structure Therapeutics shares in Q1 2025, an estimated $767K.
  • TwinBeech Capital first reported a position in Structure Therapeutics in Q4 2023 and held it in 4 quarters.
  • TwinBeech Capital's Structure Therapeutics position peaked at $1.68M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2025.

Based on TwinBeech Capital's 13F filing for Q1 2025, filed 15 May 2025.